Andere Sprachen Bora Pharmaceuticals Co., LTD.

Aktien

6472

TW0006472004

6472

Schlusskurs Taiwan S.E. Andere Börsenplätze 06.09.2024			% 5 Tage	% 1. Jan.
735,00 ^TWD	+4,11 %		-1,74 %	+15,02 %

05.09.	Bora Pharmaceuticals beantragt in Singapur die Notierung von $200 Millionen Anleihen mit Fälligkeit 2029	MT
30.08.	Bora Pharmaceuticals legt Preis für erste Anleihe fest	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bora Pharmaceuticals Files for Singapore Listing of $200 Million Bonds Due 2029	05.09.
Bora Pharmaceuticals Prices First Bond Issue	30.08.
Bora Pharmaceuticals to Merge Unit with Tanvex BioPharma	28.08.
Tanvex BioPharma, Inc. announced that it expects to receive funding from Bora Pharmaceuticals Co., LTD.	27.08.
Tanvex BioPharma, Inc. agreed to acquire Bora Biologics Co., Ltd. from Bora Pharmaceuticals Co., LTD. and others for TWD 4.52 billion.	27.08.
Bora Pharmaceuticals Closes Acquisition of Sterile Manufacturing Facility	21.08.
Emergent Biosolutions Completes Sale of Baltimore-Camden Manufacturing Site; Shares Fall	20.08.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	13.08.
Bora Pharmaceuticals USA Inc. announced that it expects to receive $200 million in funding from Bora Pharmaceuticals Co., LTD.	13.08.
Bora Pharmaceutical Laboratories Inc. announced that it expects to receive $200 million in funding from Bora Pharmaceuticals Co., LTD.	13.08.
Bora Biologics Co., Ltd. announced that it expects to receive TWD 428.04 million in funding from Bora Pharmaceuticals Co., LTD.	13.08.
Bora Biologics Co., Ltd. announced that it expects to receive TWD 500.04 million in funding from Bora Pharmaceuticals Co., LTD.	05.08.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Bora Pharmaceuticals USA Inc. announced that it expects to receive $57 million in funding from Bora Pharmaceuticals Co., LTD.	14.05.
Tranche Update on Bora Pharmaceuticals Co., LTD.'s Equity Buyback Plan announced on March 7, 2024.	07.05.
Bora Pharmaceuticals Co., LTD.'s Equity Buyback announced on March 7, 2024 has expired with 519,000 shares, representing 0.51% for TWD 389.68 million .	07.05.
Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd.	12.04.
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..	01.04.
Bora Pharmaceuticals USA Inc. announced that it expects to receive $1 billion in funding from Bora Pharmaceuticals Co., LTD.	29.03.
Bora Pharmaceuticals Co., LTD. announces an Equity Buyback for 1,000,000 shares, representing 0.99% for TWD 6,832.17 million.	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bora Pharmaceuticals Co., LTD.

Aktien

6472

TW0006472004

6472

Andere Sprachen

Filter